A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses
C. A. Arbeláez, J. Estrada, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
P. A. Weidenbacher, M. Sanyal, et al.
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma
A. Rezapour, D. Rydbeck, et al.
Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy
Y. Li, Y. Cong, et al.
A game theoretic approach identifies conditions that foster vaccine-rich to vaccine-poor country donation of surplus vaccines
A. Lampert, R. Sulitzeanu-kenan, et al.
